MicroRNA‐146a sponge therapy suppresses neointimal formation in rat vein grafts
Authors:
- 6 October 2018
- journal article
- research article
- Published by Wiley in IUBMB Life
- Vol. 71 (1) , 125-133
Abstract
The long‐term failure of vein grafts due to neointimal hyperplasia remains a difficult problem in cardiovascular surgery. Exploring novel approaches to prevent neointimal hyperplasia is important. MicroRNA‐146a (miR‐146a) plays an essential role in promoting vascular smooth muscle cell (VSMC) proliferation. Thus, the aim of the present study is to investigate whether adenovirus‐mediated miR‐146a sponge (Ad‐miR‐146a‐SP) gene therapy could attenuate neointimal formation in rat vein grafts. (Ad‐miR‐146a‐SP) was constructed to transfect cultured VSMCs and grafted veins. To improve the efficiency of transferring the miR‐146a sponge gene into the grafted veins, 20% poloxamer F‐127 gel incorporated with 0.25% trypsin was used to increase adenovirus contact time and penetration. miR‐146a‐SP transduction significantly reduced the expression of miR‐146a both in cultured VSMCs and vein grafts. miR‐146a sponge markedly attenuated VSMC proliferation and migration. Consistent with this, miR‐146a sponge gene therapy significantly attenuated neointimal formation and also improved blood flow in the vein grafts. Mechanistically, we identified the Krüppel‐like factor 4(KLF4) as a potential downstream target gene of miR‐146a in vein grafts. Our data show that miR‐146a sponge gene therapy could effectively reduce miR‐146a activity and attenuate neointimal formation in vein grafts, suggesting its potential therapeutic application for prevention of vein graft failure. © 2018 IUBMB Life, 2018Keywords
Funding Information
- National Natural Science Foundation of China (NSFC81700320)
This publication has 31 references indexed in Scilit:
- Off-Pump Coronary Artery Bypass Surgery Is Associated With Worse Arterial and Saphenous Vein Graft Patency and Less Effective RevascularizationCirculation, 2012
- Rapid Generation of MicroRNA Sponges for MicroRNA InhibitionPLOS ONE, 2012
- MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodellingCardiovascular Research, 2011
- MicroRNA-21 Regulates Vascular Smooth Muscle Cell Function via Targeting Tropomyosin 1 in Arteriosclerosis Obliterans of Lower ExtremitiesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- MicroRNA sponges: Progress and possibilitiesRNA, 2010
- MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion FormationCirculation Research, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- The evolution of gene regulation by transcription factors and microRNAsNature Reviews Genetics, 2007
- Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgeryJACC, 2004
- Pharmacokinetics of Adenoviral Vector-Mediated Gene Delivery to Vascular Smooth Muscle Cells: Modulation by Poloxamer 407 and Implications for Cardiovascular Gene TherapyHuman Gene Therapy, 1995